human lung cancer cell line a549 Search Results


90
Qinhuangdao Lihua Starch Co Ltd a549 human lung adenocarcinoma epithelial cell line
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
A549 Human Lung Adenocarcinoma Epithelial Cell Line, supplied by Qinhuangdao Lihua Starch Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549 human lung adenocarcinoma epithelial cell line/product/Qinhuangdao Lihua Starch Co Ltd
Average 90 stars, based on 1 article reviews
a549 human lung adenocarcinoma epithelial cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Yingrun Biotechnologies Inc human ubc 5637 cell line
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Human Ubc 5637 Cell Line, supplied by Yingrun Biotechnologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ubc 5637 cell line/product/Yingrun Biotechnologies Inc
Average 90 stars, based on 1 article reviews
human ubc 5637 cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Guiyang Xintian Pharmaceutical Co Ltd akebia trifoliata
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Akebia Trifoliata, supplied by Guiyang Xintian Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/akebia trifoliata/product/Guiyang Xintian Pharmaceutical Co Ltd
Average 90 stars, based on 1 article reviews
akebia trifoliata - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
AtaGenix Inc pancreatic cancer cell line mia-paca-2
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Pancreatic Cancer Cell Line Mia Paca 2, supplied by AtaGenix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pancreatic cancer cell line mia-paca-2/product/AtaGenix Inc
Average 90 stars, based on 1 article reviews
pancreatic cancer cell line mia-paca-2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Chinou Jouhou Shisutemu human lung carcinoma cell line a-549
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Human Lung Carcinoma Cell Line A 549, supplied by Chinou Jouhou Shisutemu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung carcinoma cell line a-549/product/Chinou Jouhou Shisutemu
Average 90 stars, based on 1 article reviews
human lung carcinoma cell line a-549 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Katakura Industries cells a549
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Cells A549, supplied by Katakura Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cells a549/product/Katakura Industries
Average 90 stars, based on 1 article reviews
cells a549 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
PeproTech human lung cancer cell line a549
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Human Lung Cancer Cell Line A549, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung cancer cell line a549/product/PeproTech
Average 90 stars, based on 1 article reviews
human lung cancer cell line a549 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
OncoTherapy Science Inc immortalized cell line c1r-a11
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Immortalized Cell Line C1r A11, supplied by OncoTherapy Science Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/immortalized cell line c1r-a11/product/OncoTherapy Science Inc
Average 90 stars, based on 1 article reviews
immortalized cell line c1r-a11 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Panapharm Laboratories cell line a549 human lung cancer
Cyclin D1 expression in <t>A549</t> cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.
Cell Line A549 Human Lung Cancer, supplied by Panapharm Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell line a549 human lung cancer/product/Panapharm Laboratories
Average 90 stars, based on 1 article reviews
cell line a549 human lung cancer - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Cedarlane lung alveolar epithelial cells a549
a , Configuration of AngioPlate that allocates three inlet wells and two outlet wells for each terminal lung alveoli model. b , Design of the vascularized alveoli terminal with alveolar duct and sac and the resulting network perfused with FITC microparticles (1 µm, green) and TRITC microparticles (1 µm, red) for visualization. Scale bar, 1 mm. c , Vascularized alveoli terminal seeded with GFP-HUVECs (green) and alveolar <t>epithelial</t> cells <t>(A549)</t> on day 7. Scale bar, 1mm. d-e , Image and quantification of alveolar epithelium thickening over time. f-g , Fluorescent images of the cross-section of the vascularized alveolar sac stained for F-actin (red) and DAPI (blue). h , Histology cross-section of an vascularized terminal alveoli stained with Masson’s trichrome, E-Cadherin and CD-31. scale bar, 100 µm. i , A frame of a video that shows the physical expansion of the alveoli terminal actuated by a ventilator. j-k , Vector map and quantification that show the physical expansion of an alveolar sac at different levels of ventilation pressure. Statistical significance was determined using one-way ANOVA with the Holm-Sidak method. *P≤0.05 **P≤0.01 ***P ≤0.001
Lung Alveolar Epithelial Cells A549, supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lung alveolar epithelial cells a549/product/Cedarlane
Average 90 stars, based on 1 article reviews
lung alveolar epithelial cells a549 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Evotec Inc a549 cell assays
a , Configuration of AngioPlate that allocates three inlet wells and two outlet wells for each terminal lung alveoli model. b , Design of the vascularized alveoli terminal with alveolar duct and sac and the resulting network perfused with FITC microparticles (1 µm, green) and TRITC microparticles (1 µm, red) for visualization. Scale bar, 1 mm. c , Vascularized alveoli terminal seeded with GFP-HUVECs (green) and alveolar <t>epithelial</t> cells <t>(A549)</t> on day 7. Scale bar, 1mm. d-e , Image and quantification of alveolar epithelium thickening over time. f-g , Fluorescent images of the cross-section of the vascularized alveolar sac stained for F-actin (red) and DAPI (blue). h , Histology cross-section of an vascularized terminal alveoli stained with Masson’s trichrome, E-Cadherin and CD-31. scale bar, 100 µm. i , A frame of a video that shows the physical expansion of the alveoli terminal actuated by a ventilator. j-k , Vector map and quantification that show the physical expansion of an alveolar sac at different levels of ventilation pressure. Statistical significance was determined using one-way ANOVA with the Holm-Sidak method. *P≤0.05 **P≤0.01 ***P ≤0.001
A549 Cell Assays, supplied by Evotec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549 cell assays/product/Evotec Inc
Average 90 stars, based on 1 article reviews
a549 cell assays - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Novoprotein engineered human lung carcinoma cell line a549 expressing cd19
a , Configuration of AngioPlate that allocates three inlet wells and two outlet wells for each terminal lung alveoli model. b , Design of the vascularized alveoli terminal with alveolar duct and sac and the resulting network perfused with FITC microparticles (1 µm, green) and TRITC microparticles (1 µm, red) for visualization. Scale bar, 1 mm. c , Vascularized alveoli terminal seeded with GFP-HUVECs (green) and alveolar <t>epithelial</t> cells <t>(A549)</t> on day 7. Scale bar, 1mm. d-e , Image and quantification of alveolar epithelium thickening over time. f-g , Fluorescent images of the cross-section of the vascularized alveolar sac stained for F-actin (red) and DAPI (blue). h , Histology cross-section of an vascularized terminal alveoli stained with Masson’s trichrome, E-Cadherin and CD-31. scale bar, 100 µm. i , A frame of a video that shows the physical expansion of the alveoli terminal actuated by a ventilator. j-k , Vector map and quantification that show the physical expansion of an alveolar sac at different levels of ventilation pressure. Statistical significance was determined using one-way ANOVA with the Holm-Sidak method. *P≤0.05 **P≤0.01 ***P ≤0.001
Engineered Human Lung Carcinoma Cell Line A549 Expressing Cd19, supplied by Novoprotein, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/engineered human lung carcinoma cell line a549 expressing cd19/product/Novoprotein
Average 90 stars, based on 1 article reviews
engineered human lung carcinoma cell line a549 expressing cd19 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Cyclin D1 expression in A549 cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.

Journal: Oncology Letters

Article Title: Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 in vitro

doi: 10.3892/ol.2018.7923

Figure Lengend Snippet: Cyclin D1 expression in A549 cells in groups A-E following treatment for 48 h. Lanes: A, nimotuzumab; B, cisplatin; C, nimotuzumab followed by cisplatin; D, nimotuzumab and cisplatin simultaneously; and E, untreated control.

Article Snippet: Cell culture The A549 human lung adenocarcinoma epithelial cell line (supplied by the Central Laboratory of Qinhuangdao No. 1 People's Hospital) was cultured in Dulbecco's modified Eagle's medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 10% fetal bovine serum (FBS; Zhejiang Tianhang Biotechnology Co., Ltd., Huzhou, China), 1 U/ml penicillin and 1 mg/ml streptomycin at 37°C, with 5% CO 2 and 95% humidity.

Techniques: Expressing, Control

a , Configuration of AngioPlate that allocates three inlet wells and two outlet wells for each terminal lung alveoli model. b , Design of the vascularized alveoli terminal with alveolar duct and sac and the resulting network perfused with FITC microparticles (1 µm, green) and TRITC microparticles (1 µm, red) for visualization. Scale bar, 1 mm. c , Vascularized alveoli terminal seeded with GFP-HUVECs (green) and alveolar epithelial cells (A549) on day 7. Scale bar, 1mm. d-e , Image and quantification of alveolar epithelium thickening over time. f-g , Fluorescent images of the cross-section of the vascularized alveolar sac stained for F-actin (red) and DAPI (blue). h , Histology cross-section of an vascularized terminal alveoli stained with Masson’s trichrome, E-Cadherin and CD-31. scale bar, 100 µm. i , A frame of a video that shows the physical expansion of the alveoli terminal actuated by a ventilator. j-k , Vector map and quantification that show the physical expansion of an alveolar sac at different levels of ventilation pressure. Statistical significance was determined using one-way ANOVA with the Holm-Sidak method. *P≤0.05 **P≤0.01 ***P ≤0.001

Journal: bioRxiv

Article Title: AngioPlate – Biofabrication of perfusable complex tissues in multi-well plates with 4D subtractive manufacturing

doi: 10.1101/2021.08.13.456244

Figure Lengend Snippet: a , Configuration of AngioPlate that allocates three inlet wells and two outlet wells for each terminal lung alveoli model. b , Design of the vascularized alveoli terminal with alveolar duct and sac and the resulting network perfused with FITC microparticles (1 µm, green) and TRITC microparticles (1 µm, red) for visualization. Scale bar, 1 mm. c , Vascularized alveoli terminal seeded with GFP-HUVECs (green) and alveolar epithelial cells (A549) on day 7. Scale bar, 1mm. d-e , Image and quantification of alveolar epithelium thickening over time. f-g , Fluorescent images of the cross-section of the vascularized alveolar sac stained for F-actin (red) and DAPI (blue). h , Histology cross-section of an vascularized terminal alveoli stained with Masson’s trichrome, E-Cadherin and CD-31. scale bar, 100 µm. i , A frame of a video that shows the physical expansion of the alveoli terminal actuated by a ventilator. j-k , Vector map and quantification that show the physical expansion of an alveolar sac at different levels of ventilation pressure. Statistical significance was determined using one-way ANOVA with the Holm-Sidak method. *P≤0.05 **P≤0.01 ***P ≤0.001

Article Snippet: Renal Proximal Tubule Epithelial Cells (RPTEC-TERT1, Everycyte, Cat# CHT-003-0002) and Lung Alveolar Epithelial Cells (A549, Cedarlane Labs, Cat# PTA-6231) were cultured as per manufacturer’s instructions.

Techniques: Staining, Plasmid Preparation